Press "Enter" to skip to content

FDA declines to approve Daiichi Sankyo’s blood cancer treatment

Several experts in the committee concurred that the data presented by the company was not strong enough to support an approval and called for further study.

Original source:

Also Read:   Dr Reddy's recalls all its ranitidine products in US